Dow Up 0.48% Nasdaq Up 0.43%

Imprimis Pharmaceuticals, Inc. (IMMY)

-NasdaqCM
8.25 Down 0.01(0.12%) Aug 19, 3:53PM EDT
Prev Close:8.26
Open:8.20
Bid:8.05 x 900
Ask:8.27 x 1300
1y Target Est:2.00
Beta:-2.18
Next Earnings Date:N/A
Day's Range:8.05 - 8.32
52wk Range:3.01 - 9.62
Volume:8,387
Avg Vol (3m):18,789
Market Cap:75.11M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMY

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8,439.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-10) :N/A
Quarterly EPS Est (Dec-10) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Imprimis Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focusing on the commercial development of compounded drug formulations. The company, through a strategic relationship with Professional Compounding Centers of America, I... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback